This article is available to subscribers. Subscribe now. Already have an account? Sign in

Perspective

Sunlight as Disinfectant — New Rules on Disclosure of Industry Payments to Physicians

List of authors.
  • Meredith B. Rosenthal, Ph.D.,
  • and Michelle M. Mello, J.D., Ph.D.

Will new rules requiring drug and device companies to disclose payments to physicians and teaching hospitals have the intended effects? Disclosure's benefits are unlikely to be realized without the activation of “learned intermediaries,” such as health insurers.

Continue reading this article

Select an option below:

Create your account to get 2 free subscriber-only articles each month.

Get Free Access Now Subscribe For Full Access

Already have an account?

Sign In

Print subscriber?

Activate your online access.

Funding and Disclosures

Disclosure forms provided by the authors are available with the full text of this article at NEJM.org.

Author Affiliations

From the Department of Health Policy and Management, Harvard School of Public Health, Boston.

Print Subscriber? Activate your online access.